Investing

Goldman Sachs Research Summary (JAN 19, 2007)

This morning, Goldman Sachs started 3M (MMM) and International Paper (IP) with Neutral ratings. 

Rite Aid (RAD) was downgraded from a Neutral to Sell rating after the recent stock gains.  As a reminder, this was Cramer’s #2 speculative play for 2007.  Goldman trimmed the current fiscal estimates from $0.07 to $0.03.  This was added to Goldman’s Americas Investment SELL List.

TRW Automotive (TRW) was also downgraded from a Neutral rating down to a Sell rating.  This was added to Goldman’s Americas Investment SELL List.

JDSU (JDSU) estimates were raised from $0.21 EPS up to $0.26 EPS for the current year; this after the company raised guidance last night.

Knight Capital Group (NITE) saw its estimates trimmed at Goldman Sachs from $1.32 EPS down to $1.15 for the current year and the coming year estimates were trimmed from $1.45 to $1.26.

Xilinx (XLNX) estimates were also trimmed after the company lowered guidance; Goldman cut next fiscal year from $1.22 EPS to $1.10.

Goldman Sachs also reiterated a BUY rating on J&J (JNJ) and said it sees 11% upside to its 6-month target of $75.00.  This replaces Stryker (SYK) on the Americas Conviction Buy List.

Smart Investors Are Quietly Loading Up on These “Dividend Legends”

If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.

Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.